Analyzing factors affecting pancreatic tumors and cysts
Prognostic Factors, Operative Care and Short and Long Term Outcomes for Cysts and Tumors in Pancreas and the Periampullary Region
This study looks at how different factors affect pancreatic tumors and cysts to help improve treatment options for patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Umeå University Academic / other |
| Locations | 1 site (Umeå) |
| Trial ID | NCT05155878 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze prognostic and predictive factors related to the diagnosis and surgical treatment of cysts and tumors in the pancreas and periampullary region. Participants will be enrolled both prospectively and retrospectively, allowing for a comprehensive examination of clinical outcomes based on patient and tumor characteristics. The study will utilize clinical data along with blood and tissue samples to develop and validate biomarkers that could enhance treatment strategies.
Who should consider this trial
Good fit: Ideal candidates are patients recommended for surgery due to tumors or cysts in the pancreas or periampullary region.
Not a fit: Patients who are not able to provide informed consent and are still alive at the study initiation will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic and treatment approaches for patients with pancreatic tumors and cysts.
How similar studies have performed: While similar studies have explored prognostic factors in pancreatic conditions, this specific approach focusing on biomarker development is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Recommended surgery for tumor or cyst in the pancreas or periampullary region * Information avalible in electronic journal files * Informed consent (or deceased for retrospective part of the study) Exclusion Criteria: * No informed consent (and still alive at study initiation)
Where this trial is running
Umeå
- Surgical Clinic at Umeå University Hospital — Umeå, Sweden (Recruiting)
Study contacts
- Principal investigator: Oskar Franklin, MD/PhD — University Hospital, Umeå
- Study coordinator: Oskar Franklin, MD/PhD
- Email: oskar.franklin@umu.se
- Phone: +4690785000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.